Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (608)	3/17/1998 10:15:00 AM
From: Zamin Mustafa	Respond to of 998

Sorry. My Mistake. EOM

To: Rudy Saucillo who wrote (608)	3/18/1998 10:08:00 AM
From: g.w. barnard	Read Replies (1) \| Respond to of 998

to all: does anyone get this magazine? would like to know more about the additional data???? gw FDA working "proactively and creatively" on Myotrophin data along with Cephalon, agency assures Sen. Hatch; agency maintains that additional clinical data are needed. FDA IS WORKING "PROACTIVELY AND CREATIVELY" ON MYOTROPHIN data, along with the drug's sponsor Cephalon, the agency's Associate Commissioner of Legislative Affairs Diane Thompson tells Sen. Orrin Hatch in a March 3 letter. "We can assure you that the agency is working ... [Health News Daily, 552 words]